This article was originally published in SRA
US bill introduced to reduce fake prescription drugs
You may also be interested in...
X-ray manufacturers and importers submitting Electronic Product Control reports will only need to submit their variance application package once.
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.